Bellevue Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$26.9K Hold
2025
Q2
$27.9K Sell
2025
Q1
$1.03M Sell
2024
Q4
$2.55M Sell
2024
Q3
$2.59M Sell
2024
Q2
$3.19M Buy
2024
Q1
$4.24M Buy
2023
Q4
$1.72M Buy
2023
Q3
$1.33M Buy
2021
Q3
Sell
2021
Q2
$730K Buy